Epithalon vs Thymosin Alpha-1
Epithalon and Thymosin Alpha-1 are both peptides examined in laboratory research, but they sit in different areas of study. Epithalon is a synthetic tetrapeptide investigated in longevity research for a possible influence on telomerase activity and for links to pineal signaling and circadian rhythm. Thymosin Alpha-1, originally isolated from thymic tissue, is studied in immune research for activity at toll-like receptors on dendritic cells and for its association with T-cell maturation and differentiation. Epithalon has been studied mainly in cell-culture and animal models, including telomere, neurogenesis and oocyte-aging work. Thymosin Alpha-1 has additionally been examined in human research, including chronic hepatitis B and a multicenter COVID-19 cohort study. Human safety data remain limited for both.
Key differences
- 01
Epithalon is studied for a possible influence on telomerase activity and pineal signaling, while Thymosin Alpha-1 is studied for activity at toll-like receptors on dendritic cells upstream of T-cell differentiation.
- 02
Epithalon research centers on cellular aging, telomere biology and circadian rhythm, whereas Thymosin Alpha-1 research centers on immune signaling, including T-cell maturation and NK-cell activity in immunosuppressed mouse models.
- 03
Published work on Epithalon consists mainly of cell-culture and animal studies with no controlled clinical trials among the cited literature, while Thymosin Alpha-1 has been examined in human research such as a multicenter COVID-19 cohort study and clinical work in chronic hepatitis B.
- 04
Research protocols for Epithalon have used 2–10 mg once daily in 20-day cycles repeated up to 3 times per year, whereas protocols for Thymosin Alpha-1 have used 1.5–3 mg 3 times per week in 8-week blocks with 4 weeks off.
- 05
Thymosin Alpha-1 has been investigated in immuno-oncology and immunoregulation research, while Epithalon has been explored in cell models of neurogenesis, retinopathy-related wound healing and mouse oocyte aging.
Side by side
Telomerase activator, epigenetic reset
NK + T-lymphocyte immune restoration
Preclinical
Early clinical
Longevity
Foundation
Subcutaneous
Subcutaneous
Research protocols have used 2–10 mg per administration, once daily (pre-sleep). Reported cycle: 20 consecutive days, then off; repeat up to 3 times per year (~4 months apart).
Research protocols have used 1.5–3 mg per administration, 3 times per week (morning), in 8-week blocks with 4 weeks off.
- Telomere length and telomerase activity in human cell lines
- Pineal signaling and circadian rhythm regulation
- Gene expression during neurogenesis in cell models
- Antioxidant effects on delayed wound healing in an in vitro retinopathy model
- Post-ovulatory aging of mouse oocytes in vitro
- T-cell maturation and differentiation
- Toll-like receptor signaling on dendritic cells
- NK-cell activity in immunosuppressed mouse models
- Chronic hepatitis B research
- COVID-19 in a multicenter cohort study
- Immunoregulation in cancer and immuno-oncology research
- Human safety data are limited
- Adverse events are not summarized in the cited studies
- Most evidence comes from cell-culture and animal models
- Long-term effects have not been characterized in controlled human trials
- Human safety data in the cited literature are limited
- Adverse events are not summarized in the cited studies
- A 1996 laboratory study reported that Thymosin Alpha-1 did not promote growth or oncogenic transformation
- Cell studies reported no effect on F508del-CFTR maturation or activity
5 cited studies
5 cited studies
Studied ranges describe what published research protocols have used. They are not instructions or recommendations. Products are sold for research purposes only; each order ships with a protocol guide for the specific product.
Mechanism
Epithalon
Research investigates Epithalon for interaction with telomerase and with the pineal regulation of biological rhythm, both associated with cellular aging processes.
Telomere Biology
Studied for a possible influence on telomerase activity, tied to the maintenance of chromosomal end-caps during cell division.
Circadian Regulation
Explored in research on pineal signaling and the systems coordinating rest, hormone release, and daily rhythm.
Thymosin Alpha-1
Research investigates Thymosin Alpha-1 for activity at toll-like receptors on dendritic cells, upstream of the T-cell differentiation it is most associated with.
T-Cell Maturation
Studied for its influence on the development and differentiation of T-cells within adaptive immunity.
Receptor Signaling
Explored for activity at toll-like receptors that sit early in the immune recognition cascade.
